Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Nucana Plc ADR
(NQ:
NCNA
)
1.540
-0.080 (-4.94%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Nov 1, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Nucana Plc ADR
< Previous
1
2
3
4
5
6
7
Next >
Why Telesis Bio Shares Are Trading Higher By Around 110%; Here Are 20 Stocks Moving Premarket
September 26, 2024
Via
Benzinga
NuCana Announces Grant of Composition-of-Matter Patent for NUC-7738 in the United States
September 25, 2024
From
NuCana plc
Via
GlobeNewswire
Crude Oil Surges Over 1%; Instil Bio Shares Plunge
September 16, 2024
Via
Benzinga
Exposures
Fossil Fuels
Dow Jumps Over 200 Points; NY Empire State Manufacturing Index Increases In September
September 16, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
NCNA Stock Earnings: NuCana Beats EPS for Q2 2024
August 15, 2024
NCNA stock results show that NuCana beat analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
NCNA Stock Earnings: NuCana Beats EPS for Q1 2024
May 16, 2024
NCNA stock results show that NuCana beat analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
NuCana Resistant Melanoma Treatment Data Shows Providing Some Relief After Disappointing Colorectal Cancer Data, Stock Surges
September 16, 2024
NuCana presented final data from a Phase 2 study at ESMO Congress, showing NUC-7738 combined with Keytruda achieved a 75% disease control rate in metastatic melanoma patients resistant to prior PD-1...
Via
Benzinga
Why Exicure Shares Are Trading Higher By Over 49%; Here Are 20 Stocks Moving Premarket
September 16, 2024
Via
Benzinga
NuCana Presents Encouraging Data on NUC-7738 in Combination with Pembrolizumab in PD-1 Inhibitor Refractory and Resistant Melanoma Patients at the ESMO Congress 2024
September 14, 2024
Combination of NUC-7738 plus Pembrolizumab Resulted in Prolonged Progression Free Survival, a Compelling Disease Control Rate including Partial Responses, and a Favorable Safety Profile
From
NuCana plc
Via
GlobeNewswire
12 Health Care Stocks Moving In Monday's Intraday Session
September 02, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
September 02, 2024
Via
Benzinga
NuCana Stock Plunges On Colorectal Combo Therapy Trial Setback, Ends Mid-Stage Study After Disappointing Data
August 30, 2024
NuCana will discontinue the NuTide:323 study after an initial analysis recommended by the Steering Committee, as the combination treatment was unlikely to achieve superior Progression-Free Survival...
Via
Benzinga
NuCana Announces Update for Phase 2 Randomized Colorectal Cancer Study
August 29, 2024
From
NuCana plc
Via
GlobeNewswire
Why Bit Digital Shares Are Trading Higher By Around 11%; Here Are 20 Stocks Moving Premarket
August 20, 2024
Via
Benzinga
NuCana Reports Second Quarter 2024 Financial Results and Provides Business Update
August 15, 2024
From
NuCana plc
Via
GlobeNewswire
NuCana to Present at the Jefferies Global Healthcare Conference
May 30, 2024
From
NuCana plc
Via
GlobeNewswire
NuCana to Present at TD Cowen’s 5th Annual Oncology Innovation Summit
May 21, 2024
From
NuCana plc
Via
GlobeNewswire
NuCana Reports First Quarter 2024 Financial Results and Provides Business Update
May 16, 2024
From
NuCana plc
Via
GlobeNewswire
NuCana Regains Compliance with Nasdaq Minimum Bid Price Requirement
May 01, 2024
From
NuCana plc
Via
GlobeNewswire
NuCana Announces Completion of ADS Ratio Change
April 16, 2024
From
NuCana plc
Via
GlobeNewswire
NuCana Presents Data at the AACR 2024 Annual Meeting Highlighting the Ability of NUC-7738 to Profoundly Alter Tumor Biology in a Paired Biopsy Clinical Study
April 09, 2024
From
NuCana plc
Via
GlobeNewswire
12 Health Care Stocks Moving In Thursday's After-Market Session
April 04, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
March 29, 2024
Via
Benzinga
Why Kodiak Sciences Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
March 28, 2024
Shares of Kodiak Sciences Inc. (NASDAQ: KOD) fell sharply during Thursday’s session after the company reported a wider-than-expected fourth-quarter loss. Kodiak Sciences posted a quarterly loss of...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
March 28, 2024
Via
Benzinga
Why NuCana (NCNA) Shares Are Trading Lower
March 28, 2024
NuCana shares are trading lower by 16.6% during Thursday's session. The company late Wednesday said it intends to adjust the ratio of its American Depository Shares (ADSs).
Via
Benzinga
Why RH Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket
March 28, 2024
Shares of RH (NYSE: RH) rose sharply in today’s pre-market trading following the release of quarterly results.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
March 28, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
March 28, 2024
Pre-market stock movers are a hot topic on Thursday as we check out all of the biggest stories moving shares this morning!
Via
InvestorPlace
NuCana Announces Plan to Implement ADS Ratio Change
March 27, 2024
From
NuCana plc
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.